2.25
+0.01(+0.45%)
Currency In USD
Sector
Healthcare
Industry
Medical - Devices
Employees
85
First IPO Date
April 12, 2011
| Name | Title | Pay | Year Born |
| Mr. Marvin L. Slosman | President, Chief Executive Officer & Director | 964,523 | 1964 |
| Dr. Sol J. Barer Ph.D. | Special Advisor to the Board | 13,917 | 1947 |
| Mr. Andrea Tommasoli | Chief Operating Officer | 359,269 | 1972 |
| Mr. Shane Thomas Gleason | Chief Commercial Officer | 528,016 | 1975 |
| Mr. Craig Shore | Chief Financial Officer, Chief Administrative Officer, Secretary & Treasurer | 647,396 | 1961 |
| Mr. Pete J. Ligotti | Executive Vice President & GM of North America | 0 | N/A |
| Mr. Amir Kohen | Executive Vice President of Finance & Regional Manager | 0 | N/A |
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.